Altomare C - Search Results

1

Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data.

Archer DF, Altomare C, Jiang W, Cort S. Archer DF, et al. Among authors: altomare c. Menopause. 2017 Oct;24(10):1167-1174. doi: 10.1097/GME.0000000000000900. Menopause. 2017. PMID: 28509812 Free PMC article. Clinical Trial.

2

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.

Archer DF, Goldstein SR, Simon JA, Waldbaum AS, Sussman SA, Altomare C, Zhu J, Yoshida Y, Schaffer S, Soulban G. Archer DF, et al. Among authors: altomare c. Menopause. 2019 Jan 28;26(6):611-621. doi: 10.1097/GME.0000000000001292. Menopause. 2019. PMID: 30694917 Free PMC article. Clinical Trial.

3

Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.

Simon JA, Altomare C, Cort S, Jiang W, Pinkerton JV. Simon JA, et al. Among authors: altomare c. J Womens Health (Larchmt). 2018 Jan;27(1):14-23. doi: 10.1089/jwh.2017.6385. Epub 2017 Oct 24. J Womens Health (Larchmt). 2018. PMID: 29064335 Free PMC article. Clinical Trial.

4

Ospemifene's effect on vasomotor symptoms: a post hoc analysis of phase 2 and 3 clinical data.

Constantine GD, Archer DF, Pollycove R, Jiang W, Altomare C, Pinkerton JV. Constantine GD, et al. Among authors: altomare c. Menopause. 2016 Sep;23(9):957-64. doi: 10.1097/GME.0000000000000656. Menopause. 2016. PMID: 27404027 Clinical Trial.

5

Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy.

Taylor HS, Kagan R, Altomare CJ, Cort S, Bushmakin AG, Abraham L. Taylor HS, et al. Menopause. 2017 Jan;24(1):27-34. doi: 10.1097/GME.0000000000000711. Menopause. 2017. PMID: 27575548

6

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices.

Goldstein I, Simon JA, Kaunitz AM, Altomare C, Yoshida Y, Zhu J, Schaffer S, Soulban G. Goldstein I, et al. Among authors: altomare c. Menopause. 2019 Sep;26(9):994-1001. doi: 10.1097/GME.0000000000001350. Menopause. 2019. PMID: 31453961 Free PMC article. Clinical Trial.

7

Effects of ospemifene on bone in postmenopausal women.

de Villiers TJ, Altomare C, Particco M, Gambacciani M. de Villiers TJ, et al. Among authors: altomare c. Climacteric. 2019 Oct;22(5):442-447. doi: 10.1080/13697137.2019.1631789. Epub 2019 Jul 11. Climacteric. 2019. PMID: 31294631

8

Ospemifene should be used as a single agent without progestin in postmenopausal women with an intact uterus.

Altomare C. Altomare C. Menopause. 2015 Aug;22(8):916. doi: 10.1097/GME.0000000000000512. Menopause. 2015. PMID: 26154275 No abstract available.

9

Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.

Bachmann G, Bouchard C, Hoppe D, Ranganath R, Altomare C, Vieweg A, Graepel J, Helzner E. Bachmann G, et al. Among authors: altomare c. Menopause. 2009 Jul-Aug;16(4):719-27. doi: 10.1097/gme.0b013e3181a48c4e. Menopause. 2009. PMID: 19436223 Clinical Trial.

10

No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA).

Cai B, Simon J, Villa P, Biglia N, Panay N, Djumaeva S, Particco M, Kanakamedala H, Altomare C. Cai B, et al. Among authors: altomare c. Maturitas. 2020 Dec;142:38-44. doi: 10.1016/j.maturitas.2020.06.021. Epub 2020 Jul 10. Maturitas. 2020. PMID: 33158486 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page